Adjunct immunotherapies for tuberculosis

The Journal of Infectious Diseases, 04/03/2012

A broad range of immunological treatments, including cytokine treatment or cell–based therapy, is now available, although not all have been evaluated in humans. This review gives a critical overview of current adjunct immunotherapies for active tuberculosis, which are at various stages of development.

Print Article Summary Cat 2 CME Report